123 related articles for article (PubMed ID: 24048280)
1. Adalimumab for the treatment of refractory acne conglobata.
Sand FL; Thomsen SF
JAMA Dermatol; 2013 Nov; 149(11):1306-7. PubMed ID: 24048280
[No Abstract] [Full Text] [Related]
2. Acne conglobata and adalimumab: use of tumour necrosis factor-α antagonists in treatment-resistant acne conglobata, and review of the literature.
Yiu ZZ; Madan V; Griffiths CE
Clin Exp Dermatol; 2015 Jun; 40(4):383-6. PubMed ID: 25545016
[TBL] [Abstract][Full Text] [Related]
3. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) with E250K mutation in CD2BP1 gene treated with the tumor necrosis factor inhibitor adalimumab.
Lee H; Park SH; Kim SK; Choe JY; Park JS
Clin Exp Rheumatol; 2012; 30(3):452. PubMed ID: 22513199
[No Abstract] [Full Text] [Related]
4. Adalimumab for pyoderma gangrenosum associated with inflammatory bowel disease.
Cariñanos I; Acosta MB; Domènech E
Inflamm Bowel Dis; 2011 Dec; 17(12):E153-4. PubMed ID: 21953808
[No Abstract] [Full Text] [Related]
5. Long-term treatment of severe SAPHO syndrome with adalimumab: case report and a review of the literature.
Garcovich S; Amelia R; Magarelli N; Valenza V; Amerio P
Am J Clin Dermatol; 2012 Feb; 13(1):55-9. PubMed ID: 22007948
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndrome successfully treated with adalimumab.
Prica A; Buckstein R
J Clin Oncol; 2015 Jan; 33(2):e4-6. PubMed ID: 24567429
[No Abstract] [Full Text] [Related]
7. Efficacy of adalimumab for a refractory case of relapsing polychondritis with reduction of pro-inflammatory cytokines.
Nakamura H; Suzuki T; Nagaoka K; Yamasaki S; Tamai M; Hayashi T; Kawakami A
Mod Rheumatol; 2011 Dec; 21(6):665-8. PubMed ID: 21509650
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of Adalimumab in Crohn's disease].
Serghini M; Haddad W; Jeddi H; Karoui S; Ben Mustapha N; Kallel L; Fekih M; Matri S; Boubaker J; Filali A
Tunis Med; 2012 Feb; 90(2):101-7. PubMed ID: 22407620
[TBL] [Abstract][Full Text] [Related]
9. [Level of adalimumab and its antibody titers define the effectiveness of the biological (anticytokine) therapy in Crohn's disease].
Lazebnik LB; Sagynbaeva VÉ
Eksp Klin Gastroenterol; 2013; (7):18-22. PubMed ID: 24772870
[TBL] [Abstract][Full Text] [Related]
10. Adalimumab treatment may replace or enhance the activity of steroids in steroid-refractory tuberculous meningitis.
Lee HS; Lee Y; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
J Infect Chemother; 2012 Aug; 18(4):555-7. PubMed ID: 22045163
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic noninfectious uveitis in children--the trend toward tumor necrosis factor-alpha inhibition.
Cunningham ET
J AAPOS; 2013 Oct; 17(5):451-3. PubMed ID: 24160960
[No Abstract] [Full Text] [Related]
12. Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab.
De Wet J; Jordaan HF; Kannenberg SM; Tod B; Glanzmann B; Visser WI
Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447652
[TBL] [Abstract][Full Text] [Related]
13. [Adalimumab].
Aubin F; Barthelemy H
Ann Dermatol Venereol; 2011 Dec; 138(12):842-4. PubMed ID: 22137624
[No Abstract] [Full Text] [Related]
14. PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition.
Saraceno R; Babino G; Chiricozzi A; Zangrilli A; Chimenti S
J Am Acad Dermatol; 2015 Jan; 72(1):e42-4. PubMed ID: 25497954
[No Abstract] [Full Text] [Related]
15. Adalimumab for the treatment of inflammatory bowel disease.
Wasan SK; Kane SV
Expert Rev Gastroenterol Hepatol; 2011 Dec; 5(6):679-84. PubMed ID: 22017695
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with adalimumab in a patient with psoriatic arthritis and generalized pustular psoriasis.
Kimura U; Kinoshita A; Sekigawa I; Takamori K; Suga Y
J Dermatol; 2012 Dec; 39(12):1071-2. PubMed ID: 22506677
[No Abstract] [Full Text] [Related]
17. Alopecia universalis successfully treated with adalimumab.
Gorcey L; Gordon Spratt EA; Leger MC
JAMA Dermatol; 2014 Dec; 150(12):1341-4. PubMed ID: 25322338
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of adalimumab for refractory serpiginous choroiditis.
Chinchurreta Capote A; Requena Jiménez JM; Lorenzo Soto M; Romero Gómez C; García de Lucas MD
Ocul Immunol Inflamm; 2014 Oct; 22(5):405-8. PubMed ID: 24304367
[No Abstract] [Full Text] [Related]
19. 'Bamboo spine', a thing of the past?
Haroon N; Danda D
Int J Rheum Dis; 2014 Feb; 17(2):127-30. PubMed ID: 24576268
[No Abstract] [Full Text] [Related]
20. Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.
Díaz-Llopis M; Salom D; Garcia-de-Vicuña C; Cordero-Coma M; Ortega G; Ortego N; Suarez-de-Figueroa M; Rio-Pardo MJ; Fernandez-Cid C; Fonollosa A; Blanco R; Garcia-Aparicio AM; Benitez-Del-Castillo JM; Olea JL; Arevalo JF
Ophthalmology; 2012 Aug; 119(8):1575-81. PubMed ID: 22525047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
